Method for providing uniform feed flow inside a plug flow reactor.

The PFR system with co-current or counter-current circulation in bioprocessing addresses non-uniform feed stream issues, achieving efficient homogenization and simplifying sanitation in virus inactivation processes.

JP7578729B2Active Publication Date: 2024-11-06BOEHRINGER INGELHEIM INT GMBH
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2022577119
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-06-16
Filing Date
2021-06-11
Publication Date
2024-11-06
Estimated Expiration
2041-06-11

AI Technical Summary

Technical Problem

Existing bioprocessing methods for continuous virus inactivation and homogenization of feed streams in push flow reactors (PFRs) face challenges such as non-uniform feed stream compositions, which result in variable viscosities and protein concentrations, leading to inefficiencies and complications in downstream processing.

Method used

The use of a push flow reactor (PFR) with a bypass line and pumps for in-line homogenization, employing co-current or counter-current circulation to reduce concentration differences in the feed stream, ensuring a homogeneous composition before further processing.

Benefits of technology

The PFR system effectively attenuates peak concentrations by 70% to 90%, reducing processing time and simplifying sanitation, while maintaining a consistent feed stream for virus inactivation and downstream operations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007578729000001
    Figure 0007578729000001
  • Figure 0007578729000002
    Figure 0007578729000002
  • Figure 0007578729000003
    Figure 0007578729000003
Patent Text Reader

Abstract

An apparatus and method for in-line homogenization of a heterogeneous feed stream is described. The present invention includes a plug flow reactor (PFR), a bypass line, and a pump with a closed circuit flow path that allows rapid homogenization of the non-uniform feed stream.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates generally to the field of biotechnology production, and more specifically to continuous bioprocessing and an apparatus and method for in-line homogenization of a feed stream in a plug flow reactor (PFR). [Background technology]

[0002] In continuous bioprocessing, at least one unit operating in the production cascade receives a continuous input of the material of interest without interruption. An essential element for continuous bioprocessing is simultaneous or continuous viral inactivation (CVI), and the necessary steps after the appropriate chromatographic purification steps may include bind-elute column chromatography, such as Protein A (ProA) chromatography. For example, a product or material of interest of variable concentration may be eluted from a ProA column in a manner described by an asymmetric Gaussian curve that is primarily based on the inherent characteristics of the particular bind-elute column (Figure 1). The next step in the bioprocess after bind-elute column chromatography attempts to homogenize the product feed stream before further analysis, using a surge vessel, such as a tank or bag, direct transfer tubing, or alternatives such as recycling the feed stream. The following prior art documents are examples of the state of the art, including their inherent defects and shortcomings:

[0003] WO 2014 / 004103 teaches a system design and method for the in-line addition of a viral inactivation reagent, such as an acid or a detergent, to a composition that continuously comprises a biological product, which uses one or more in-line static mixers having mixing elements to combine the biological product with the viral inactivation reagent during flow from a first unit operation to a second unit operation.

[0004] WO 2015 / 158776 teaches a system design and method that uses a surge vessel to continuously bind a virus inactivation reagent, such as an acid or detergent, to a composition containing a biological product to inactivate viruses that may be present in the composition. In particular, blending multiple column elution cycles makes troubleshooting difficult if a deviation from normal operation occurs in one of the cycles, as the blending process obscures the location of the errant product. Also, a surge vessel or open circuit homogenization loop makes sanitization of the system difficult, as the system's product retention cannot be easily accommodated.

[0005] US Patent Application 2018 / 0117495 teaches a process for continuous purification of target biological molecules in which viruses are inactivated in-line within a continuous purification system by a method of in-line blending of ProA elution peaks within an open circuit flow path where previously eluted peaks are mixed backwards with the currently eluting peak. This technique utilizes an open circuit homogenization loop to direct the product flow through an inlet and an outlet during mixing. This methodology aims to redistribute the acid used to minimize attenuation of the ProA peak as it travels through the system and to lower the pH more uniformly. The relative flow rates utilized in this system design and method are not ideal for process scale-up. The flow rates during the redistribution or recirculation step are 90 times faster than the incubation step.

[0006] An additional attempt to avoid the surge vessel implements a tankless retentate that captures one elution cycle for subsequent transfer of the heterogeneous feed stream to a unit where the heterogeneous feed stream (containing the protein or product of interest) to the next step of the process is replaced with a non-product-containing fluid, thereby discharging the product to prepare for the required cleaning / disinfection process before the next cycle is captured. However, this strategy typically cannot perform homogenization because the feed stream remains heterogeneous after repeated circulation (Figure 11). It is well known in the art that heterogeneous feed stream composition leads to variable viscosity and variable protein concentration, both of which have adverse effects on downstream CVI steps. Thus, there is a need for an apparatus or method that reduces or eliminates these complications. Summary of the Invention

[0007] The present invention solves the above-mentioned problems with the methods and apparatus disclosed herein, resulting in faster and better homogenization of a heterogeneous feed stream (e.g., from a ProA column) than existing techniques.

[0008] In one or more aspects, embodiments, the present invention is directed to an apparatus for in-line homogenization of a heterogeneous feed stream. In our system, an elution product, defined as a feed stream containing at least a product of interest, is first stored inside a push flow reactor (PFR) as a heterogeneous feed stream that is variable in that the concentration of the stream has a maximum and a minimum concentration. The contained heterogeneous feed stream is then circulated until the difference between the maximum and minimum concentrations is reduced to a sufficient extent, the maximum concentration is sufficiently reduced, or the minimum concentration is sufficiently increased.

[0009] In one embodiment, an apparatus for in-line homogenization of a heterogeneous feed stream includes (a) a plug flow reactor (PFR), (b) a bypass line for diverting a portion of the heterogeneous feed stream from a first location inside the PFR to a second location within the flow channel, and (c) a pump for circulating the heterogeneous feed stream through the flow channel. In a preferred embodiment, the heterogeneous feed stream comprises a protein or product of interest.

[0010] In another embodiment, the device is placed in-line between a first process step and a second process step. In one aspect, the first process step is a bind-elute column (protein A) chromatography. In one aspect, the second process step is a virus inactivation step. In another aspect of the device, the flow path is a closed circuit flow path. In yet another aspect, the device is tankless.

[0011] In one embodiment, the PFR includes a tubing assembly filled into at least one chamber. The device may also include a bypass line as an extension of the flow path fluidly connecting to a location inside the flow path. In one aspect, the second location is downstream of the first location. In another aspect, the second location is upstream of the first location. Alternatively, the second location is located inside the PFR downstream or upstream of the first location. In one aspect of the device, the pump is selected from the group consisting of centrifugal pumps and / or positive displacement pumps. The device may further include a second pump in the flow path, the second pump modulating the flow of the non-uniform feed stream in the bypass line. In another aspect, the second pump is a pump selected from the group consisting of centrifugal pumps and / or positive displacement pumps. In one aspect, the flow of the non-uniform feed stream in the bypass line is co-current or counter-current to the flow of the non-uniform feed stream in the flow path.

[0012] In another embodiment, a method for in-line homogenization of a heterogeneous feed stream is provided, the method comprising: (a) providing a heterogeneous feed stream; (b) flowing the heterogeneous feed stream through a flow path including a PFR bypass line and a pump; (c) diverting a percentage of the heterogeneous feed stream from a first location inside the PFR to a second location inside the flow path; (d) circulating the heterogeneous feed stream through the flow path; and (e) homogenizing the heterogeneous feed stream. In a preferred embodiment, the method comprises a protein or product of interest. In one aspect of the method, the flow path is in-line between the first and second process steps. In an alternative aspect, the first process step is Protein A (ProA) column chromatography. The second process step in the method can be a viral inactivation step. In an embodiment, the method is directed to viral inactivation.

[0013] In one embodiment, the flow path is a closed circuit flow path and the PFR includes a piping assembly filled with at least one chamber. In another aspect, the bypass line is an extension of the flow path that fluidly connects a first and a second location within the flow path. The second location in this method can be located downstream of the first location, or the second location can be located upstream of the first location, or the second location can be located inside the PFR, i.e., downstream or upstream of the first location.

[0014] In another embodiment of the method, the pump is selected from the group consisting of a centrifugal pump and / or a positive displacement pump. In one aspect, the method further comprises a second pump in the flow path, the second pump modulating the flow of the non-uniform feed stream in the bypass line. Alternatively, the method includes a second pump selected from the group consisting of a centrifugal pump and / or a positive displacement pump.

[0015] In one embodiment, the flow of the non-uniform feed stream within the bypass line is parallel or countercurrent to the flow of the non-uniform feed stream within the flow path. In one aspect, the bypass line bypasses the non-uniform feed stream at a flow rate of about 1% to about 99% of the fastest flow rate of the flow path.

[0016] In one or more embodiments, the present invention is directed to a method for producing a product of interest by means of the device as defined. The present invention is also directed to a method for producing a protein by means of the device defined above. In a preferred embodiment, the protein is a therapeutic protein.

[0017] In one or more embodiments, the present invention is directed to a method for producing a product of interest by a method for in-line homogenization of a heterogeneous feedstream as defined above. The present invention is also directed to a method for producing a protein by a heterogeneous feedstream as defined above. In a preferred embodiment, the protein is a therapeutic protein.

[0018] Additional features and advantages of various embodiments, aspects will be set forth in, or will be obvious from, the description that follows, or may be learned by practice of the various embodiments. The objectives and other advantages of the various embodiments will be realized and attained by use of the elements and combinations particularly pointed out in the description herein.

[0019] The present disclosure, certain aspects and embodiments thereof, can be more fully understood from the detailed description, the claims, and the accompanying drawings. [Brief description of the drawings]

[0020] [Figure 1] 1 is a graph showing the relative concentration of protein eluates obtained from Protein A column chromatography represented by an asymmetric Gaussian curve based on the inherent characteristics of the bind-elute process. The X-axis shows the column volume of the elution stream, and the Y-axis shows the relative concentration (%) of the eluate. [Diagram 2] 1 illustrates an exemplary multiple extrusion flow reactor. [Diagram 3] 3 illustrates the flow patterns in each of the extruder flow reactors shown in FIG. 2 according to examples of the present disclosure. [Figure 4] 1 illustrates the relationship of a Protein A chromatography column to a flow circulation device according to an embodiment of the present disclosure. [Figure 5A]FIG. 5(A) illustrates an example of a co-current circulation apparatus having two plug flow reactors for homogenizing a heterogeneous concentrated feed stream composition according to an example of the present disclosure. [Figure 5B] FIG. 5(B) illustrates an example of a co-current circulation apparatus having two plug flow reactors for homogenizing a heterogeneous concentrated feed stream composition according to an example of the present disclosure. [Figure 6] 1 shows an alternative co-current flow apparatus having six extruder flow reactors for homogenizing a heterogeneous concentrated feed stream composition according to an example of the present disclosure. [Figure 7] 1 shows a countercurrent circulation apparatus having six plug flow reactors for homogenizing a heterogeneous concentrated feed stream composition according to an example of the present disclosure. [Figure 8] 1 shows experimental results of circulating material around a simple non-PFR length of tubing to homogenize the composition. [Figure 9] The washout volume of a simple non-PFR length of piping is shown, and the results are shown in Figure 8. [Figure 10] 1 shows a conventional in-line circulation experimental setup. [Figure 11] The results of the experimental setup in FIG. 10 are shown. [Figure 12] 7 shows results of the experimental setup of FIG. 6 according to an example of the present disclosure. [Figure 13] 5(a) and 5(b) show pH, conductivity and UV per volume associated with the experimental setup shown in FIG. 5(a) and 5(b), according to an embodiment of the present disclosure. [Figure 14] 5(a) and 5(b) show protein concentrations after 30 minutes of circulation using the experimental setup shown in FIG. 5(a) and 5(b), according to an embodiment of the present disclosure. [Figure 15] FIG. 5 shows the washout volume required to wash away proteins using the experimental setup shown in FIG. 5(a) and FIG. 5(b), according to an embodiment of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0021] The following description is intended to be illustrative and non-limiting to describe various embodiments of the present invention.

[0022] The present disclosure is directed to an apparatus and process for providing an intimate mixture, i.e., homogenization of a solution containing a bioengineered product after one or more chromatographic purification steps.

[0023] In order that the present invention may be more readily understood, the following terms are defined below. Additional definitions are also set forth throughout the detailed description.

[0024] definition As used herein, the term "Extrusion Flow Reactor (PFR)", also referred to as a "Jig in a Box (JIB)" or "Circulation Loop", refers to a piping system or assembly (forming a flow path) compressed in a 3D space or chamber. An embodiment of a PFR can act as an elution flow chamber (ESC) or tankless hold used between process steps, where the discharge from the process to the next process step flows through the PFR in a purification process. An embodiment of a PFR may include two or more chambers, as shown in FIG. 2. For example, in biopharmaceutical processing, the eluate streams of different volumes flowing from at least one bind-elute (Protein A (ProA)) column of the PFR may have one or more chambers fluidly connected to extend the flow path of a portion or the entire volume of the feed stream. A PFR may be used as a hold between two process steps, for example, between a bind-and-elute step, or a ProA step, and a viral inactivation step. A PFR may also be a vessel used to provide residence time for a viral inactivation step. A PFR also includes a bypass line. A PFR of the present invention also has a bypass line.

[0025] A "pump" is a device that moves a fluid from one location, a first location, along a flow path to another location, or from the second location along a flow path that is positionally different from the first location, through mechanical action.

[0026] As used herein, the term "chamber" or "PFR chamber" refers to a portion of a piping assembly of a PFR. A PFR chamber can include one or more loops or rows arranged in a continuous flow passage, line, conduit, or tube of a given specific length and volume.

[0027] In an embodiment, the PFR holds or collects the entire volume of the output from a process step, allowing for a continuous flow of output from one process step to the next (e.g., bind and elute or ProA and viral inactivation steps). In another embodiment, the volume of the PFR is about six times (6x, 6x, or 600%) the overall product containing the volume of the output from the previous process step. In another embodiment, the volume of the PFR is about 500%, about 400%, about 300%, about 200%, about 150%, about 130%, about 120%, or about 110% of the total product containing the volume of the output from the previous process step. In an alternative embodiment, the volume of the PFR is about 100% of the total product-containing volume of the output from the previous process step. In another embodiment, the volume of the PFR is less than or equal to 95%, 85%, 75%, 65%, 55%, 50% (half), 45%, 35%, 25%, 15%, 10% or 5% of the total product containing the volume of discharge from the previous process step.

[0028] As used herein, the term "bypass line" in the context of a PFR refers to a tube or conduit that can divert about 1% to about 99% of the fastest fluid velocity from a first location to a second location of a homogenization apparatus of the present invention. See, for example, lines 152 of FIG. 5(a) and FIG. 5(b). The first and second locations can be inside or outside the PFR, provided that one of the locations is inside the PFR. For example, the bypass line can divert 25% of the flow rate from a first location inside the PFR to a second location outside the PFR within a flow path or piping system that circulates the feed stream through the PFR. Alternatively, the bypass line can divert about 1% to about 99%, or about 10% to about 90%, or about 20% to 80%, or about 25% to 75% of the flow rate of the PFR from the first location to the second location. In an example, the bypass line is an extension of the PFR flow path that short-circuits a path between a first location and a second location by fluidly connecting two locations within the flow path. In an embodiment, the non-uniform feed stream flow in the bypass line operates in a co-current or counter-current direction to the non-uniform feed stream flow of the flow path. In another embodiment, the bypass line includes a pump that modulates the non-uniform feed stream flow into or through the bypass line in a co-current or counter-current direction to the non-uniform feed stream flow of the flow path or the PFR.

[0029] As used herein, the term "substantially homogenized" refers to a feedstream (e.g., a bind and elute, or ProA eluate stream) whose concentration profile has changed from a bell-shaped curve (e.g., FIG. 1) to an approximately linear one. For example, a substantially homogenized feedstream can be one in which the difference in concentration of the feedstream between the maximum and minimum concentrations contained within the PFR has been reduced to a sufficient range. In another example, a substantially homogenized feedstream can be one in which the peak maximum concentration (e.g., heterogeneous ProA elution) has been attenuated by about 50% to about 99%. In embodiments, a substantially homogenized feedstream has a concentration peak maximum that is attenuated by about 50%, 60%, 70%, or about 80%, or about 90%, or about 95%, or about 99% compared to the maximum concentration peak of the same feedstream prior to homogenization.

[0030] The term "in-line" or "in-line operation" refers to a process of moving a liquid sample through a tube or some other conduit without storage in a vessel, tank, or bag. Thus, in some embodiments, according to the present invention, a PFR is used in an "in-line operation" to transfer a liquid sample containing a target protein from one process step to another.

[0031] The term "viral inactivation" or "VI" refers to the treatment of a sample potentially containing one or more viruses in such a way that the one or more viruses can no longer replicate or are inactivated. Viral inactivation can be achieved by physical means, such as heat, ultraviolet light, ultrasonic vibration, or by chemical means, such as a change in pH or the addition of chemical virus inactivation reagents, and is a typical process step used during most protein purification processes, especially in the case of purification of therapeutic proteins. In the methods described herein, VI is performed using one or more in-line PFRs.

[0032] The term "virus inactivating agent" or "virus inactivating agent" refers to any physical or chemical means capable of rendering one or more viruses inactive or non-replicative. As used by the methods described herein, a virus inactivating agent can include a change in solution conditions (e.g., pH, conductivity, temperature, etc.) or the addition of, for example, a solvent / detergent, salt, polymer, small molecule, drug molecule, or any other suitable entity that interacts with one or more viruses in the sample, or a physical means (e.g., exposure to UV light, vibration, etc.), such that exposure to the virus inactivating agent renders one or more viruses inactive or non-replicative. In certain embodiments, the virus inactivating agent is a change in pH, and the virus inactivating agent is mixed with a sample containing the target molecule (e.g., the eluate obtained from a Protein A binding and elution chromatography step) using a PFR.

[0033] To reach the desired product stream pH target as the feed stream elutes from the ProA column (taking into account the intrinsic buffering capacity of the product), two approaches can be implemented: (1) the acid addition rate needs to be varied as a function of protein concentration, or (2) a fixed volumetric addition of acid needs to be strong enough to bring the worst case conditions (i.e., the peak maximum with the highest protein concentration) to the pH set point.

[0034] Alternatively or additionally, to avoid complications associated with product elution peaks such as variable viscosity and acid addition (i.e., variable amounts of acid required to achieve a pH set point as a function of protein concentration or a fixed volumetric addition as a function of protein concentration in the worst case), the peak concentrations may be mixed so that the entire feed stream is of similar concentration and / or composition. Furthermore, feed streams should not be mixed in containers such as tanks or bags, as these containers cannot be easily sanitized, cannot be completely emptied of protein elution every cycle, and the feed stream may leak due to breakage, bursting from overpressurization, or any method that may expose the feed stream to the environment. Tanks and bags also have the complexity of accommodating the air-liquid interface.

[0035] Thus, the apparatus and method described herein avoids the above-mentioned complications and homogenizes the feed stream significantly faster and more efficiently than existing systems; i.e., it can be easily disinfected, it has no gas-liquid interface, and is less prone to leaks due to its rigid structure and design. Without wishing to be bound by any particular theory, the present invention is based, in part, on the unexpected discovery that a heterogeneous ProA elution feed stream (shown in FIG. 1) can be effectively homogenized in an in-line, continuous, tankless system by applying co-current and / or counter-current flow to the feed stream as it travels through one or more PFRs.

[0036] In an example, a plug flow reactor (PFR) 100 is shown in Figure 2. The exemplary PFR 100 shown in the figure includes six chambers 100a-100f.

[0037] As shown in FIG. 3, each PFR 100 or chamber thereof includes a tubular flow path 112 that includes turns or curves 110. Details of similar PFRs are described in detail in PCT Application No. PCT / US2019 / 054959, the entire contents of which are incorporated herein by reference. As previously mentioned, the flow paths are designed to change and / or shift the direction of curvature from one turn to the next to enhance radial mixing and reduce axial dispersion, but complete mixing is not achieved even after the feed stream turns through the PFR more than 17 times. See FIG. 11.

[0038] Referring to FIG. 4, in an example, the heterogeneous feed stream composition is a ProA elution stream from a ProA chromatography column 130. In general, the total volume of the PFR 100 can be about 1 to about 6 times the volume of the ProA chromatography column 130, excluding the volume inside the fluid lines such as fluid lines 151, 152, 155 and 156 (also shown in FIG. 5). The volume of the elution inside fluid lines 151, 152, 155 and 156 relative to the PFR 100 can be about 10% to 0.5%, or about 7% to 3%, or a volume selected from the group consisting of about 20%, about 15%, about 10%, about 7%, about 5%, about 3%, about 1% and about 0.5%. In an embodiment, the volume of fluid lines 151, 152, 155 and 156 is about 3%, or about 2.2%, or about 1.6% of the total volume of the PFR 100, depending on the length of the fluid lines.

[0039] 5(a) and 5(b), in an example, the apparatus may also include at least a first pump 134, an optional second pump 136 (to adjust the flow of the non-uniform feed stream in the bypass line 152), a number of optional valves 141-148, and a number of fluid lines numbered consecutively 151-157. In an embodiment, the valves 141, 144, 145, 146, and / or 147 may be optional. In an example, each pair of valves 141 and 142, 143 and 144, or 147 and 148 may be combined and replaced by a three-way value. Those skilled in the art will understand that the locations of the values ​​or pumps, or their number or type, are not limited as shown and may be arranged differently to achieve similar results of the present disclosure. First, to load the example, a first set of valves 142 and 143 are switched to an open position and a second set of valves 141, 144, 145, 146, 147 and 148 are switched to a closed position to load the PFR 100 with a heterogeneous feed stream, e.g., a ProA eluate stream, from column chromatography 130. The ProA eluate stream can then be transferred to the PFR 100 via feed stream line 154 and fluid line 155, displacing the fluid retained therein from fluid lines 156 and 157, as shown in FIG. 5(a).

[0040] 5(b), once the ProA eluate stream from column chromatography 130 is contained within PFR 100, the first set of valves 142 and 143 are switched to a closed position and the second set of valves 141, 144, 145, 146, 147 and 148 are switched to an open position to form a closed circuit loop or flow path such that there are no inlets or outlets to the flow path. Then, each of the first and second pumps 134 and 136 may circulate the ProA eluate stream several times through fluid lines 151, 152, 155 and 156 such that the ProA eluate stream is homogenized (i.e., forming a uniform concentrated feed stream composition) by mixing at the junction of flow lines 151 and 152.

[0041] In an example, as shown in Figures 5 and 6, the device homogenizes a heterogeneous feed stream (e.g., a ProA elution stream) by cocurrent circulation. Cocurrent circulation is achieved by a bypass line (i.e., streamline 152) that diverts a predetermined percentage of the circulating feed stream (defined as the feed rate) from a first location in the flow path to a second location downstream of the first location in the closed circuit flow path, thereby reducing the flow rate in a portion of the flow line.

[0042] Referring to FIG. 5(b), in an example, the PFR 100 includes two chambers in fluid communication with each other. As discussed above, the size of the PFR depends on the volume of the Protein A elution stream. In this example, when the first set of valves 142 and 143 are closed and the second set of valves 141, 144, 145, 146, 147 and 148 are opened, the first pump 134 pushes the ProA elution stream through line 155 towards chamber 2 of the PFR 100. The bypass line 152 diverts about 30% to about 90%, such as about 50% to about 80%, such as about 75%, of the ProA elution stream from a first location in the PFR to a second location inside the closed circuit flow path including the PFR and lines 151, 155 and 156. The remaining ProA eluate stream can continue to flow into chamber 1 of the PFR 100 and then exit the PFR 100 via flow lines 156 and 151 towards the first pump 134. Before reaching the first pump 134, the bypass line 151 merges with flow line 152, causing the ProA eluate in each of the two flow lines 151 and 152 to mix. The first pump 134 then redirects the combined ProA eluate stream through line 155 to the PFR 100 for yet another circulation round.

[0043] In an embodiment, the first pump 134 and the second pump 136 have different flow rates. For example, the flow rate of the second pump 136 is less than the flow rate of the first pump 134. In another embodiment, the flow rate of the second pump 136 is defined as a pump that operates at a flow rate less than the flow rate of the first pump 134 such that it can divert about 1% to about 99% of the total reactor flow rate (i.e., in this particular example, the total passing through the first pump 134), such as about 10% to about 90% of the total reactor flow rate, or about 50% to about 80%, such as about 75% of the total reactor flow rate.

[0044] In an embodiment, the PFR 100 can be configured such that when a heterogeneous concentrated feed stream, such as that shown in Figure 1, is introduced into the PFR 100 and circulated a predetermined number of times in a closed circuit flow path represented by fluid lines 155, 156, 151, 152 and pump 134, the heterogeneous concentrated feed stream is substantially homogenized. See Figure 12. In an embodiment, a heterogeneous concentrated feed stream is fed through a PFR of the present invention and is at least 20%, 25%, 30%, 35%, 40%, 50%, 60%, 70%, 80%, 90% or 100% homogenized.

[0045] In an example, FIG. 6 shows a co-current circulation system for homogenizing a non-uniform feed stream (e.g., a ProA elution feed stream). The co-current circulation method or apparatus may be characterized by a PFR in which a bypass line 152 diverts a percentage of the fluid flow from a first location of the PFR to a second location downstream of the first location, resulting in a reduced flow rate in some of the flow lines. As shown, a first pump 134 drives the feed stream to the PFR 100 via line 151. With the help of a second pump 136, the bypass line 152 diverts approximately 50% of the flow rate from the first location (e.g., the first chamber) of the PFR 100 to a second location (e.g., the fifth chamber) downstream of the first location. Given that 50% of the feed stream has been diverted from the first chamber of the PFR 100, the second, third, and fourth chambers contain only 50% of the flow rate when represented by "1×". The diverted and undiverted feed streams join in the fifth chamber of the PFR 100. The combined feed stream then flows to the sixth chamber where the bypass line 152 again diverts the combined feed stream from chamber 1 to chamber 5, thus again repeating the flow pattern described above. In this example, the flow rate of the first pump 134 is approximately twice the flow rate of the second pump 136.

[0046] The cocurrent circulation process may be repeated a sufficient number of times such that the maximum peak concentration of the heterogeneous ProA elution is attenuated to about 70% to about 90%. For example, the circulation process can be repeated about 3 to about 20 times, such as about 5 to about 10 times, for example 6 times. Alternatively, the circulation process can be repeated for a predetermined time, such as about 10 minutes to about 3 hours, for example about 30 minutes.

[0047] In another example, as shown in FIG. 7, a countercurrent circulation system for homogenizing a non-uniform feed stream (e.g., a ProA elution feed stream) is shown. The countercurrent circulation method or apparatus may be characterized by a PFR in which a bypass line diverts a portion of the fluid flow from a first location in the PFR to a second location upstream of the first location, resulting in an increased flow rate in the portion of the flow line. As shown, in the countercurrent example, the flow rate of the second pump 136 is defined by being a pump operating at a flow rate equal to or less than the flow rate of the first pump 134. With the aid of the pump 136, the bypass line 152 bypasses anywhere from about 1% to about 100% of the total flow rate from a first location (e.g., chamber 4) to a second location (e.g., chamber 1) within the PFR 100. In embodiments, the bypass line diverts about 10% to about 90% of the total flow, or about 50% to about 80%, or about 40%, or about 50%, or about 60%, or about 75% of the flow, from a first location in the PFR to a second location upstream of the first location. The combined feed stream then flows through the PFRs of chambers 2-4, and bypass line 152 again diverts the combined feed stream from chamber 4, again repeating the above flow pattern.

[0048] The countercurrent circulation process may be repeated a sufficient number of times such that the maximum peak concentration of the heterogeneous ProA elution is attenuated by about 70% to about 90%. For example, the circulation process can be repeated about 3 times to about 20 times, such as about 5 times to about 10 times, for example, 6 times. Alternatively, the circulation process can be repeated for a predetermined period of time, such as about 10 minutes to about 3 hours, for example, about 30 minutes.

[0049] Alternatively or additionally, FIG. 7 shows a countercurrent circulation device for homogenizing the ProA elution stream exiting the column chromatography. In this example, the PFR 100 has six chambers. The first pump 134 drives the ProA elution stream into the PFR 100 at chamber 1 via flow line 151. The ProA elution stream then travels from chamber 1 to chamber 4, where the bypass line 152 (with the help of the second pump 136) diverts 1 / 3 (or 1X) of the maximum flow rate of the ProA elution stream from there to the second chamber to generate a combined (or 3X) ProA elution stream. The combined (3X) ProA elution stream then flows into the second, third and fourth chambers of the PFR 100. At the end of the fourth chamber of the PFR 100, the bypass line 152 again diverts the elution stream (1X) to chamber 2, and the same flow pattern is repeated. This process is repeated a sufficient number of times such that the maximum peak concentration of the non-uniform ProA elution is attenuated by about 70% to about 90%. For example, the circulation process can be repeated about 3 times to about 20 times, such as about 5 times to about 10 times, such as 6 times. Alternatively, the circulation process can be repeated for a predetermined time, such as about 10 minutes to about 3 hours, such as about 30 minutes. In this example, the flow rate of the first pump 134 is about twice the flow rate of the second pump 136.

[0050] In each of the cocurrent and countercurrent circulation devices, either pump can be any combination of centrifugal and positive displacement pumps, such that both are positive displacement pumps, both are centrifugal pumps, or one is centrifugal and one is positive displacement. More preferably, the first pump 134 (i.e., the pump that operates faster) can be a centrifugal pump and the second pump 136 (i.e., the pump that operates slower) can be a positive displacement pump. These pumps govern the fluid dynamics of the design (e.g., preventing pressure and pump stalling issues). Furthermore, each of the cocurrent and countercurrent circulation devices can include a loading flow rate of at least 200 mL / min and an output flow rate to the incubation chamber of about 43 mL / min or more. Furthermore, each of the cocurrent and countercurrent circulation devices can include a loop volume of at least 3 times the volume of the chromatography column and a maximum flow rate of about 3.5 times or more of elution flow rate (e.g., flow rate of about 700 mL / min or more) or 16.3 times the flow rate for the loop tracking.

[0051] Working Example Example 1 Homogenizing uneven feed streams using piping systems To homogenize a heterogeneous feed stream, one solution would circulate the material around a length of tubing to homogenize the composition. Mechanistically, this occurs due to the axial dispersion experienced by the liquid flowing through the tube. Figure 8 shows an experiment in which a protein was eluted and circulated through a length of tubing. After circulating the protein approximately six times, the UV A280 trace, which translates to protein concentration, becomes relatively flat. This change indicates complete mixing.

[0052] Once mixing was complete, the mixed protein had to be pushed in-line out of the tube to the next unit operation without significantly dispersing the contents. The same mechanism that caused the mixing (i.e., axial dispersion) also caused significant product tailing, which ultimately resulted in time and product loss. Figure 9 shows the mixing loop outflow, where the CV is the column volume relative to the column volume of the eluted Protein A (ProA) column. This tailing also added complexity to sanitizing and rinsing the equipment, as the required volume exceeded 7.5 CV, further increasing the time and volume required for the process.

[0053] Example 2 Homogenizing non-uniform feed streams using PFR systems As described in PCT / US Patent Application No. 2019 / 054959 Materials: The PFR features a repeating serpentine flow path. The PFR was 3D printed using stereolithography (SLA) technology at 3D Systems (Rock Hill, SC). Riboflavin used in the fabrication of the mobile phase and pulse tracer was purchased from Thermo Fisher Scientific (Suwanee, GA).

[0054] To homogenize the non-uniform feed stream, another solution could be to use a PFR system as shown in Figure 10. The PFR was designed to break up the axial dispersion by generating radial mixing via a Dean vortex. This radial mixing is perfect to allow filling and flushing the vessel to minimize time and volume requirements, but is not optimal for circulation. To confirm that a simple solution would not work, an experiment was performed in which 1 L of riboflavin was inserted into a 3 L PFR and circulated. Figure 10 shows the experimental setup.

[0055] As shown in FIG. 11, after about 17 passes, the peak maximum decayed by only about 10%.

[0056] Example 3 Homogenization of Heterogeneous Feed Streams Using the PFR System of the Present Invention In an attempt to devise a more effective means of mixing the peaks of the PFR while maintaining the ability to empty the PFR, two designs were created, as shown in FIGS.

[0057] The co-current design (Figure 6) features the creation of a bypass line to move some of the circulating liquid further downstream, resulting in a reduced flow rate in some of the flow lines. The counter-current design (Figure 7) features the creation of a return line to move some of the circulating liquid further upstream, resulting in an increased flow rate in some of the flow lines. Figure 12 shows the results of an experiment conducted using the co-current method. Variables tested in these designs included: location in the closed loop of the bypass / return line, change / alternation between co-current and counter-current methods during the experiment, and flow rate ratio of the pumps.

[0058] On the other hand, the parallel flow design produced less pressure. Regarding the spacing of the bypass lines, an equal volumetric distance of the bypass lines was chosen because it would require two identical PFRs, as seen in Figures 5(a) and 5(b). The pump that ran faster was a centrifugal pump and is called the Primary Circulation Pump (PCP). The pump that ran slower was a positive displacement pump called the Secondary Mixing Pump (SMP). The selection and placement of these pumps is critical to the fluid dynamics of the design (e.g., preventing pressure and pump deadlock issues).

[0059] The designs shown in Figures 5(a) and 5(b) containing proteins were tested, so Figures 13, 14 and 15 show the elution peaks originating from a ProA column, the mixing in the reactor and the traces from the subsequent washout, respectively. The ProA elution curve shown in Figure 14 is obtained from a 1 L ProA column. The peak maximum of the elution peak has a high enough protein concentration that the UV detector of the chromatography skid is saturated, and the A280 curve appears to have a flat maximum at about 4000 mAu. However, the mixing portion of the run shown in Figure 14 used a variable pathlength UV detector (FlowVPE), which is less susceptible to saturation and was able to capture the peak maximum at 60 g / L before mixing.

[0060] The key takeaways from this set of experimental data are that the protein peak maximum of approximately 60 g / L was attenuated to 8-14 g / L and that the subsequent protein washout took 3.8 CV.

[0061] From the foregoing description, those skilled in the art can appreciate that the present teachings can be implemented in a variety of forms. Thus, although these teachings have been described with reference to specific embodiments and examples thereof, the true scope of the present teachings should not be so limited. Various changes and modifications can be made without departing from the scope of the teachings herein.

[0062] The scope of this disclosure should be broadly construed. This disclosure is intended to disclose equivalents, means, devices, and methods for achieving the devices, activities, and mechanical operations disclosed herein. For each device, article, method, means, mechanical element, or mechanism disclosed, this disclosure is intended to encompass that disclosure as well as to teach equivalents, means, devices, and methods for implementing the many aspects, mechanisms, and devices disclosed herein. Furthermore, this disclosure relates to coatings and many aspects, features, and elements thereof. Because such devices may be dynamic in their use and operation, this disclosure is intended to encompass equivalents, means, devices, and methods of use of the devices and / or articles of manufacture, and many aspects thereof that are consistent with the description and spirit of the operations and functions disclosed herein. The claims of this application should likewise be broadly construed.

[0063] The description of the invention herein, in its many embodiments, is merely illustrative and, therefore, variations that do not depart from the gist of the invention are intended to be within the scope of the invention. Such variations should not be regarded as departures from the spirit and scope of the invention.

Claims

1. 1. An apparatus for in-line homogenization of a heterogeneous feed stream, comprising: The flow path is (a) Plug flow reactor (PFR); (b) a bypass line for diverting a portion of the non-uniform feed flow from a first location inside the PFR to a second location within the flow path; (c) a first pump for circulating the non-uniform feed stream through the flow path; a second pump disposed in the flow path for diverting a portion of the non-uniform feed flow from a first location inside the PFR to a second location within the flow path; An apparatus comprising:

2. The apparatus of claim 1 , wherein the heterogeneous feed stream comprises a protein or product of interest.

3. The apparatus of claim 1 , wherein the apparatus is in-line between a first process step and a second process step.

4. 4. The apparatus of claim 3, wherein the first process is selected from the group consisting of bind and elute chromatography and Protein A chromatography.

5. The apparatus of claim 3 , wherein the second process step is a viral inactivation step.

6. The device of claim 1 , wherein the device is for viral inactivation.

7. The device of claim 1 , wherein the flow path is a closed circuit flow path.

8. The apparatus of claim 1 , wherein the apparatus is tankless.

9. The apparatus of claim 1 , wherein the PFR comprises a piping assembly filled into at least one chamber.

10. The apparatus of claim 1 , wherein the bypass line is an extension of the flow path that fluidly connects to a location within the flow path.

11. The apparatus of claim 1 , wherein the second location is downstream of the first location.

12. The apparatus of claim 1 , wherein the second location is upstream of the first location.

13. The apparatus of claim 1 , wherein the second location is inside the PFR downstream or upstream of the first location.

14. 10. The apparatus of claim 1, wherein the first pump is a pump selected from the group consisting of a centrifugal pump and a positive displacement pump.

15. The apparatus of claim 1 , wherein the second pump modulates the non-uniform supply flow in the bypass line.

16. 10. The apparatus of claim 1, wherein the second pump is a pump selected from the group consisting of a centrifugal pump and a positive displacement pump.

17. The apparatus of claim 1 , wherein the non-uniform feed stream flow in the bypass line is co-current or counter-current to the non-uniform feed stream flow in the flow passage.

18. The apparatus of claim 1 , wherein the non-uniform feed stream flow in the bypass line is co-current or counter-current to the non-uniform feed stream flow in the flow passage.

19. 1. A method for in-line homogenization of a heterogeneous feed stream, comprising: (a) providing a non-uniform feed flow; (b) passing the non-uniform feed stream through a flow path including a PFR bypass line and a pump; (c) diverting, with a second pump, a proportion of the non-uniform feed flow from the first location inside the PFR to a second location within the flow path; (d) circulating the non-uniform feed stream through the flow path with a first pump; and (e) homogenizing said heterogeneous feed stream.

20. 20. The method of claim 19, wherein the heterogeneous feedstream comprises a protein or product of interest.

21. 20. The method of claim 19, wherein the flow path is in-line between a first process step and a second process step.

22. 22. The method of claim 21 , wherein the first process step is Protein A (ProA) column chromatography.

23. 22. The method of claim 21 , wherein the second process step is a viral inactivation step.

24. 20. The method of claim 19, wherein the method is for viral inactivation.

25. 20. The method of claim 19, wherein the flow path is a closed circuit flow path.

26. The method of claim 19, wherein the PFR (100) includes a piping assembly filled in at least one chamber.

27. 20. The method of claim 19, wherein the bypass line (152) is an extension of the flow path that fluidly connects the first and second locations within the flow path.

28. The method of claim 19 , wherein the second location is downstream of the first location.

29. The method of claim 19 , wherein the second location is upstream of the first location.

30. 20. The method of claim 19, wherein the second location is inside the PFR downstream or upstream of the first location.

31. 20. The method of claim 19, wherein the first pump is a pump selected from the group consisting of a centrifugal pump and a positive displacement pump.

32. 20. The method of claim 19, wherein the second pump regulates the non-uniform feed flow in the bypass line.

33. 20. The method of claim 19, wherein the second pump is a pump selected from the group consisting of a centrifugal pump and a positive displacement pump.

34. 20. The method of claim 19, wherein the non-uniform feed stream flow in the bypass line is co-current or counter-current to the non-uniform feed stream flow in the flow path.

35. 35. The method of claim 34, wherein the bypass line diverts the non-uniform feed flow at a flow rate between about 1% and 99% of the flow rate of the flow path.

36. 13. A method of producing a product of interest by the apparatus of claim 1.

37. A method for producing a protein by the apparatus of claim 1.

38. 38. The method of claim 37, wherein the protein is a therapeutic protein.

39. 20. A method for producing a product of interest by in-line homogenization of a heterogeneous feed stream according to claim 19.

40. 20. A method for producing a protein by in-line homogenization of a heterogeneous feedstream according to claim 19.

41. 41. The method of claim 40, wherein the protein is a therapeutic protein.

Citation Information

Patent Citations

  • Overpressure protection

    DE102018003676A1

  • Method and system of manufacturing nanoparticle

    JP2007210092A

  • Apparatus for processing a liquid comprising a target substance

    WO2019158906A1

  • A novel continuous flow reactor for low PH viral inactivation

    WO2020076681A1